Balyasny Asset Management
ARRY

Balyasny Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Balyasny Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-190,000
Closed -$2.81M – 1952
2018
Q3 		$2.81M Buy
+190,000
New +$2.91M 0.01% 887
2017
Q2 		– Sell
-570,000
Closed -$5.1M – 1900
2017
Q1 		$5.1M Buy
+570,000
New +$6.06M 0.02% 698

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Balyasny Asset Management's ARRY Position: Q3 2019 in Review

Balyasny Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 313,796 shares — an estimated $14.5M sold.

Balyasny Asset Management first reported a position in ARRY in Q2 2013 and held it in 19 quarters. The position peaked at $23.3M in Q4 2017. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Balyasny Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Balyasny Asset Management sold 313,796 Array Biopharma Inc shares in Q3 2019, an estimated $14.5M.
  • Balyasny Asset Management first reported a position in Array Biopharma Inc in Q2 2013 and held it in 19 quarters.
  • Balyasny Asset Management's Array Biopharma Inc position peaked at $23.3M in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Balyasny Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.